<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39377521</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1758-8111</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Clinical obesity</Title><ISOAbbreviation>Clin Obes</ISOAbbreviation></Journal><ArticleTitle>Association of obesity status and the risk of long-COVID: Isfahan COVID cohort study.</ArticleTitle><Pagination><StartPage>e12708</StartPage><MedlinePgn>e12708</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cob.12708</ELocationID><Abstract><AbstractText>People with COVID-19 infection continue to have their symptoms or develop new ones after recovery. This is called long-COVID syndrome. We aimed to examine the association of general and abdominal obesity with long COVID. This study was conducted using Isfahan COVID Cohort (ICC). Totally 4008 including 3213 hospitalized and 795 non-hospitalized patients with positive RT-PCR were included. Body mass index (BMI) and waist circumference (WC) were calculated. BMI &gt;25&#x2009;kg/m<sup>2</sup> and WC &gt;88&#x2009;cm in women and 102&#x2009;cm in men were considered generally and abdominally obese, respectively. By using an open-ended questionnaire, subjects were asked whether they had any new or persistent symptom. Reported symptoms were categorized in three different fields including general, cardiac, and respiratory symptoms. Higher BMI and WC tended to increase general symptoms (odds ratio [OR] for BMI&#x2009;=&#x2009;1.16, 95 % confidence interval (95% CI): 0.97, 1.38, and OR for WC&#x2009;=&#x2009;1.14, 95% CI: 0.99, 1.32). Higher BMI significantly increased cardiovascular (OR&#x2009;=&#x2009;1.38, 95% CI: 1.14, 1.67) and respiratory symptoms (OR&#x2009;=&#x2009;1.43, 95% CI: 1.15, 1.78). Compared with patients with normal WC, the risk of cardiovascular (OR&#x2009;=&#x2009;1.44, 95% CI: 1.24, 1.69) and respiratory symptoms was significantly higher in subjects with abdominal obesity (OR&#x2009;=&#x2009;1.31, 95% CI: 1.10, 1.56). We found that general and abdominal obesity were associated with increased risk of cardiovascular and respiratory symptoms in patients with long-COVID symptoms. However, only general obesity was associated with increased risk of general symptoms.</AbstractText><CopyrightInformation>&#xa9; 2024 World Obesity Federation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohammadifard</LastName><ForeName>Noushin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arefian</LastName><ForeName>Mohadeseh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najafian</LastName><ForeName>Jamshid</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahsanaei</LastName><ForeName>Azadeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javanbakht</LastName><ForeName>Sahel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmoudi</LastName><ForeName>Shirin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouri</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayyah</LastName><ForeName>Maedeh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilforoushzadeh</LastName><ForeName>Farzaneh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmadian</LastName><ForeName>Mahshid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vice Chancellery of Health Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haghighatdoost</LastName><ForeName>Fahimeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarrafzadegan</LastName><ForeName>Nizal</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6828-2169</Identifier><AffiliationInfo><Affiliation>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>199093</GrantID><Agency>Isfahan University of Medical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Obes</MedlineTA><NlmUniqueID>101560587</NlmUniqueID><ISSNLinking>1758-8103</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">body mass index</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">post COVID</Keyword><Keyword MajorTopicYN="N">waist circumference</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>8</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377521</ArticleId><ArticleId IdType="doi">10.1111/cob.12708</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2010;875.</Citation></Reference><Reference><Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737&#x2010;754.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post&#x2010;COVID&#x2010;19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2010;e107.</Citation></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144.</Citation></Reference><Reference><Citation>Sarrafzadegan N, Mohammadifard N, Javanmard S, et al. Isfahan COVID cohort study: rationale, methodology, and initial results. J Res Med Sci. 2022;27(1):65.</Citation></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2010;442.</Citation></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC. Post&#x2010;COVID syndrome: incidence, clinical Spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021;52(6):575&#x2010;581.</Citation></Reference><Reference><Citation>Righi E, Mirandola M, Mazzaferri F, et al. Determinants of persistence of symptoms and impact on physical and mental wellbeing in long COVID: a prospective cohort study. J Infect. 2022;84(4):566&#x2010;572.</Citation></Reference><Reference><Citation>Vimercati L, De Maria L, Quarato M, et al. Association between long COVID and overweight/obesity. J Clin Med. 2021;10(18):4143.</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427.</Citation></Reference><Reference><Citation>World Health Organization. Clinical Management of Severe Acute Respiratory Infection when Novel Coronavirus (2019&#x2010;nCoV) Infection Is Suspected: Interim Guidance, 28 January 2020. World Health Organization; 2020. Contract No.: WHO/nCoV/Clinical/2020.3.</Citation></Reference><Reference><Citation>Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO expert consultation on waist circumference and waist&#x2013;hip ratio. Eur J Clin Nutr. 2010;64(1):2&#x2010;5.</Citation></Reference><Reference><Citation>Lear SA, James PT, Ko GT, Kumanyika S. Appropriateness of waist circumference and waist&#x2010;to&#x2010;hip ratio cutoffs for different ethnic groups. Eur J Clin Nutr. 2010;64(1):42&#x2010;61.</Citation></Reference><Reference><Citation>Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5(7):161.</Citation></Reference><Reference><Citation>Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID&#x2010;19&#x2010;related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death &#x2010; United States, march&#x2010;December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(10):355&#x2010;361.</Citation></Reference><Reference><Citation>Xiang M, Wu X, Jing H, Novakovic VA, Shi J. The intersection of obesity and (long) COVID&#x2010;19: hypoxia, thrombotic inflammation, and vascular endothelial injury. Front Cardiovasc Med. 2023;10:1062491.</Citation></Reference><Reference><Citation>Loosen SH, Jensen BO, Tanislav C, Luedde T, Roderburg C, Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross&#x2010;sectional study from 50,402 COVID&#x2010;19 patients. Infection. 2022;50(5):1165&#x2010;1170.</Citation></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non&#x2010;hospitalized adults. Nat Med. 2022;28(8):1706&#x2010;1714.</Citation></Reference><Reference><Citation>Bridger Staatz C, Bann D, Ploubidis GB, Goodman A, Silverwood RJ. Age of first overweight and obesity, COVID&#x2010;19 and long COVID in two British birth cohorts. J Epidemiol Glob Health. 2023;13(1):140&#x2010;153.</Citation></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post&#x2010;acute sequelae of COVID&#x2010;19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157&#x2010;1172.</Citation></Reference><Reference><Citation>Kim HW, Belin de Chantem&#xe8;le EJ, Weintraub NL. Perivascular adipocytes in vascular disease. Arterioscler Thromb Vasc Biol. 2019;39(11):2220&#x2010;2227.</Citation></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, et al. A review of persistent post&#x2010;COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021;64:66&#x2010;74.</Citation></Reference><Reference><Citation>Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin Neurosci. 2023;77(2):84&#x2010;93.</Citation></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post&#x2010;viral fatigue and COVID&#x2010;19: lessons from past epidemics. Fatigue. 2020;8(2):61&#x2010;69.</Citation></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, et al. Challenges in defining long COVID: striking differences across literature, electronic health records, and patient&#x2010;reported information. medRxiv. 2021;2021:21253896.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>